期刊文献+

丙酮酸脱氢酶复合物E2亚单位重组蛋白体外刺激PBC患者PBMCs实验研究 被引量:1

Peripheral blood T cell responses to recombinant PDC-E2 in primary biliary cirrhosis
下载PDF
导出
摘要 目的:初步探讨丙酮酸脱氢酶复合物的E2亚单位(PDCE2)与原发性胆汁性肝硬化(PBC)发病机制间的关系.方法:用纯化的PDCE2重组蛋白体外刺激PBC患者外周血单个核细胞(PBMCs);3HTdR掺入法检测PBMCs增殖情况;ELASA法检测细胞上清中TNFα含量.结果:11例M2抗体阳性和1例AMA阳性的PBC患者中有8例出现不同程度PBMCs增殖,而2例AMA和M2抗体均阴性的PBC患者和4例AIH患者PBMCs均无增殖.11例M2抗体阳性的PBC患者刺激后TNFα分泌均明显增加.结论:PBC患者外周血中存在针对PDCE2的自身反应性T细胞;TNFα可能在PBC的病理损伤中发挥重要作用. AIM: To evaluate the peripheral blood T cell responses to PDC-E2 and its possible role in the pathogenesis of primary biliary cirrhosis (PBC). METHODS: Fourteen patients with PBC and four patients with autoimmune hepatitis (AIH) were enrolled in this study. Peripheral blood mononuclear cells (PBMCs) were stimulated by purified recombinant PDC-E2. Stimulation index was measured by ~3H-TdR incorporation assay and TNF-a was detected in the supernatant of culture by ELISA. RESULTS: The proliferation of PBMCs was observed in 8 out of the 14 PBC patients, who were antimitochomdrial antibody (AMA) or anti-M2 positive. AMA positivity or anti-M2 positivity was not observed in AIH patients. TNF-a secretion increased significantly after stimulation in all the 11 anti-M2 positive PBC patients. CONCLUSION: The results suggest the possibility of using PDC-E2 as a target antigen to induce autoimmune damage in PBC and that TNF-a may play an important role in this damage.
机构地区 解放军
出处 《第四军医大学学报》 北大核心 2005年第13期1185-1188,共4页 Journal of the Fourth Military Medical University
基金 国家自然科学基金(30300320) 军队"十五"医学科研课题(04M013)
关键词 胆汁性肝硬化 外周血单个核细胞 丙酮酸脱氢酶复合物 肿瘤坏死因子 liver cirrhosis, biliary peripheral blood mononuclear cells pyruvate dehydrogenase complex TNF-α
  • 相关文献

参考文献12

  • 1Okamoto R,Yamamoto K,Yabushita K,et al.T cell repertoire in primary biliary cirrhosis:A common T cell clone and repertoire change after treatment[J].J Clin Immunol,2001;21:278.
  • 2Nishio A,Van de Water J,Leung PS,et al.Comparative studies of antimitochondrial autoantibodies in sera and bile in primary biliary cirrhosis[J].Hepatology,1997;25:1085-1089.
  • 3Heathcote EJ.Management of primary biliary cirrhosis[J].Hepatology,2000;31:1005-1013.
  • 4赵军,舒翠莉,雷历,李靖,高蓉,程云.丙酮酸脱氢酶复合物E_2亚单位的克隆表达与临床应用[J].中华肝脏病杂志,2003,11(10):602-604. 被引量:2
  • 5Joplin R,Lindsay JG,Johnson GD,et al.Membrane dihydrolipoamide acetyl transferase (E2) on human biliary epithelial cells in primary biliary cirrhosis[J].Lancet,1992;339:93-94.
  • 6Tsuneyama K,Van de water J,Leung PSC,et al.Abnormal expression of E2 component of the pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before major histocompatibility complex class II and BB1/B7 expression[J].Hepatology,1995;21:1031.
  • 7Kita H,Matsumura S,He XS,et al.Quantitative and functional analysis of PDC E2 specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis[J].J Clin Invest,2002;109(9):1231-1240.
  • 8Zou JP,Morford LA,Chougnet C,et al.Human glioma induced immunosuppression involves soluble factor(s) that alters monocyte cytokine profile and surface markers[J].J Immunol,1999;162:4882-4892.
  • 9Hanada S,Harada M,Koga H,et al.Tumor necrosis factor alpha and interferon gamma directly impair epithelial barrier function in cultured mouse cholangiocytes[J].Liver Int,2003;23(1):3-11.
  • 10龚非力.医学免疫学(第2版)[M].北京:科学出版社,2005.76-83.

二级参考文献3

共引文献2

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部